# Study of 18F-Fluoro-PEG6-IPQA

> **NCT01320059** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** 18F-PEG6-IPQA
- **PROCEDURE:** Positron emission tomography (PET)

## Key facts

- **NCT ID:** NCT01320059
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2016-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01320059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01320059, "Study of 18F-Fluoro-PEG6-IPQA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01320059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*